Deals Of The Week: Janssen/CorImmun, AstraZeneca/Cellworks, Ferring/Albireo

To the familiar sounds of the Fourth of July and mid-summer, Deals of the Week adds another: the sound of the next shoe dropping in biopharmaceutical merger-and-acquisition activity. What happens next after the $5 billion-plus buyout of Amylin by Bristol-Myers?